中文产业新闻精选评分62Chinese source
Ultragenyx 基因疗法 FAYUVI 获 FDA 批准用于 MPS IIIA，定价 395 万美元
又一罕见病基因疗法FDA获批，395万美元一针
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
又一罕见病基因疗法FDA获批，395万美元一针
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.